46681 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 03
00:54 UTC
|
SPCX
SpaceX
|
◎ Target | Timothy Horan ★★★★☆ #858 | Outperform | $250.00→ $280.00+12.0% |
|
Sep 03
00:54 UTC
|
SFIX
Stitch Fix
|
◎ Target | Jay Sole ★★☆☆☆ #2700 | Neutral | $4.50→ $4.00-11.1% |
|
Sep 03
00:54 UTC
|
ROK
Rockwell Automation
|
◎ Target | Christopher Snyder ★☆☆☆☆ #3042 | Overweight | $525.00→ $545.00+3.8% |
|
Sep 03
00:54 UTC
|
PSON
Pearson
|
◎ Target | firm only | Neutral | GBX 1,300→ GBX 1,345+3.5% |
|
Sep 03
00:54 UTC
|
PSA
Public Storage
|
◎ Target | Nicholas Yulico ★★★☆☆ #2125 | Sec→ r Outperform | $346.00→ $343.00-0.9% |
|
Sep 03
00:54 UTC
|
PSA
Public Storage
|
◎ Target | Ravi Vaidya not yet tracked | Neutral | $316.00→ $319.00+0.9% |
|
Sep 03
00:54 UTC
|
PCG
Pacific Gas & Electric
|
◎ Target | Aidan Kelly ★★★☆☆ #2132 | Overweight | $25.00→ $18.00-28.0% |
|
Sep 03
00:54 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Catharine Trebnick ★★★☆☆ #2015 | Buy | $355.00→ $415.00+16.9% |
|
Sep 03
00:54 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Gray Powell ★★★☆☆ #1092 | Buy | $380.00→ $404.00+6.3% |
|
Sep 03
00:54 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Shyam Patil ★★★★☆ #718 | Positive | $350.00→ $415.00+18.6% |
|
Sep 03
00:54 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Rudy Kessinger ★★★☆☆ #1458 | Buy | $345.00→ $420.00+21.7% |
|
Sep 03
00:54 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Matthew Hedberg ★★★☆☆ #1799 | Outperform | $434.00→ $475.00+9.4% |
|
Sep 03
00:54 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Fatima Boolani ★★★☆☆ #1285 | Buy | $400.00→ $410.00+2.5% |
|
Sep 03
00:54 UTC
|
OVV
Ovintiv
|
◎ Target | Sam Margolin ★★★☆☆ #1275 | Overweight | $78.00→ $79.00+1.3% |
|
Sep 03
00:54 UTC
|
ORCL
Oracle
|
◎ Target | Brent Thill ★★★☆☆ #1657 | Buy | $320.00→ $290.00-9.4% |
|
Sep 03
00:54 UTC
|
OKE
ONEOK
|
◎ Target | Michael Blum ★☆☆☆☆ #2909 | Overweight | $98.00→ $106.00+8.2% |
|
Sep 03
00:54 UTC
|
OKE
ONEOK
|
◎ Target | Gabe Daoud not yet tracked | Hold | $93.00→ $104.00+11.8% |
|
Sep 03
00:54 UTC
|
OKE
ONEOK
|
◎ Target | Julien Dumoulin-Smith not yet tracked | Hold | $95.00→ $105.00+10.5% |
|
Sep 03
00:54 UTC
|
NIO
NIO
|
◎ Target | Eunice Lee ★★☆☆☆ #2728 | Market Perform | $6.00→ $5.00-16.7% |
|
Sep 03
00:54 UTC
|
NHI
National Health Investors
|
◎ Target | Michael Lewis ★★☆☆☆ #2653 | Buy | $81.00→ $80.00-1.2% |
|
Sep 03
00:54 UTC
|
NAVN
Navan
|
◎ Target | Nafeesa Gupta ★★☆☆☆ #2321 | Buy | $26.00→ $34.00+30.8% |
|
Sep 03
00:54 UTC
|
MUR
Murphy Oil
|
◎ Target | Noah Hungness ★★☆☆☆ #2625 | Equal Weight | $45.00→ $41.00-8.9% |
|
Sep 03
00:54 UTC
|
MMED
MiniMed Group
|
◎ Target | Joanne Wuensch ★★★☆☆ #1591 | Buy | $23.00→ $26.00+13.0% |
|
Sep 03
00:54 UTC
|
MMED
MiniMed Group
|
◎ Target | Patrick Wood ★★★☆☆ #1365 | Buy | $25.00→ $28.00+12.0% |
|
Sep 03
00:54 UTC
|
MMED
MiniMed Group
|
◎ Target | Anthony Petrone ★★★☆☆ #2197 | Outperform | $21.00→ $26.00+23.8% |
|
Sep 03
00:54 UTC
|
MMED
MiniMed Group
|
◎ Target | Larry Biegelsen ★★★☆☆ #1863 | Overweight | $22.00→ $26.00+18.2% |
|
Sep 03
00:54 UTC
|
MMED
MiniMed Group
|
◎ Target | Travis Steed ★★★☆☆ #2061 | Buy | $24.00→ $28.00+16.7% |
|
Sep 03
00:54 UTC
|
MDT
Medtronic
|
◎ Target | Bob Hopkins not yet tracked | Buy | $95.00→ $110.00+15.8% |
|
Sep 03
00:54 UTC
|
MDT
Medtronic
|
◎ Target | Larry Biegelsen ★★★☆☆ #1863 | Overweight | $102.00→ $104.00+2.0% |
|
Sep 03
00:54 UTC
|
MDT
Medtronic
|
◎ Target | David Rescott ★★★☆☆ #1891 | Neutral | $91.00→ $100.00+9.9% |
|
Sep 03
00:54 UTC
|
MDT
Medtronic
|
◎ Target | Rick Wise ★★★☆☆ #1848 | Hold | $80.00→ $95.00+18.8% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Keith Bachman ★★★☆☆ #1510 | Outperform | $500.00→ $450.00-10.0% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Karl Keirstead ★★★☆☆ #1203 | Neutral | $460.00→ $410.00-10.9% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Matthew Broome not yet tracked | Outperform | $400.00→ $460.00+15.0% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Rishi Jaluria ★★★☆☆ #2070 | Outperform | $515.00→ $465.00-9.7% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Raimo Lenschow ★★★☆☆ #1823 | Overweight | $460.00→ $480.00+4.3% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Kash Rangan ★★★★★ #62 | Buy | $453.00→ $520.00+14.8% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Blair Abernethy ★★★☆☆ #2117 | Buy | $395.00→ $445.00+12.7% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Brad Reback ★★★☆☆ #2021 | Buy | $475.00→ $465.00-2.1% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Patrick Colville ★★★☆☆ #1731 | Sec→ r Outperform | $395.00→ $440.00+11.4% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | David Hynes ★★★☆☆ #1890 | Buy | $400.00→ $480.00+20.0% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Sanjit Singh ★★★☆☆ #1403 | Overweight | $380.00→ $430.00+13.2% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Brian White ★★★☆☆ #1841 | Buy | $460.00→ $500.00+8.7% |
|
Sep 03
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Firoz Valliji not yet tracked | Outperform | $449.00→ $484.00+7.8% |
|
Sep 03
00:54 UTC
|
LMB
Limbach
|
◎ Target | Rob Brown not yet tracked | Buy | $90.00→ $95.00+5.6% |
|
Sep 03
00:54 UTC
|
LLOY
Lloyds Banking Group
|
◎ Target | firm only | Buy | GBX 125→ GBX 127+1.6% |
|
Sep 03
00:54 UTC
|
JCI
Johnson Controls International
|
◎ Target | Chris Snyder not yet tracked | Overweight | $175.00→ $180.00+2.9% |
|
Sep 03
00:54 UTC
|
JAN
JAN
|
◎ Target | Nicholas Yulico ★★★☆☆ #2125 | Outperform | $30.00→ $31.00+3.3% |
|
Sep 03
00:54 UTC
|
IRON
Disc Medicine
|
◎ Target | David Nierengarten ★★★☆☆ #1720 | Outperform | $88.00→ $100.00+13.6% |
|
Sep 03
00:54 UTC
|
HUBB
Hubbell
|
◎ Target | Chris Snyder not yet tracked | Equal Weight | $565.00→ $575.00+1.8% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.